228 related articles for article (PubMed ID: 30069577)
1. PET imaging of EGFR expression using an
Cheng S; Jacobson O; Zhu G; Chen Z; Liang SH; Tian R; Yang Z; Niu G; Zhu X; Chen X
Eur J Nucl Med Mol Imaging; 2019 Apr; 46(4):948-956. PubMed ID: 30069577
[TBL] [Abstract][Full Text] [Related]
2. 18F-Labeled Single-Stranded DNA Aptamer for PET Imaging of Protein Tyrosine Kinase-7 Expression.
Jacobson O; Weiss ID; Wang L; Wang Z; Yang X; Dewhurst A; Ma Y; Zhu G; Niu G; Kiesewetter DO; Vasdev N; Liang SH; Chen X
J Nucl Med; 2015 Nov; 56(11):1780-1785. PubMed ID: 26315836
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and evaluation of [
Li X; Hu K; Liu W; Wei Y; Sha R; Long Y; Han Y; Sun P; Wu H; Li G; Tang G; Huang S
Nucl Med Biol; 2020; 90-91():84-92. PubMed ID: 33189948
[TBL] [Abstract][Full Text] [Related]
4. Comparison of two site-specifically (18)F-labeled affibodies for PET imaging of EGFR positive tumors.
Su X; Cheng K; Jeon J; Shen B; Venturin GT; Hu X; Rao J; Chin FT; Wu H; Cheng Z
Mol Pharm; 2014 Nov; 11(11):3947-56. PubMed ID: 24972326
[TBL] [Abstract][Full Text] [Related]
5. RNA Aptamers for Theranostics of Glioblastoma of Human Brain.
Kopylov AM; Fab LV; Antipova O; Savchenko EA; Revishchin AV; Parshina VV; Pavlova SV; Kireev II; Golovin AV; Usachev DY; Pavlova GV
Biochemistry (Mosc); 2021 Aug; 86(8):1012-1024. PubMed ID: 34488577
[TBL] [Abstract][Full Text] [Related]
6. PET of EGFR expression with an 18F-labeled affibody molecule.
Miao Z; Ren G; Liu H; Qi S; Wu S; Cheng Z
J Nucl Med; 2012 Jul; 53(7):1110-8. PubMed ID: 22689926
[TBL] [Abstract][Full Text] [Related]
7. Imaging of human epidermal growth factor receptor type 2 expression with 18F-labeled affibody molecule ZHER2:2395 in a mouse model for ovarian cancer.
Heskamp S; Laverman P; Rosik D; Boschetti F; van der Graaf WT; Oyen WJ; van Laarhoven HW; Tolmachev V; Boerman OC
J Nucl Med; 2012 Jan; 53(1):146-53. PubMed ID: 22173842
[TBL] [Abstract][Full Text] [Related]
8. PET of malignant melanoma using 18F-labeled metallopeptides.
Ren G; Liu Z; Miao Z; Liu H; Subbarayan M; Chin FT; Zhang L; Gambhir SS; Cheng Z
J Nucl Med; 2009 Nov; 50(11):1865-72. PubMed ID: 19837749
[TBL] [Abstract][Full Text] [Related]
9. PET imaging of HER2 expression with an 18F-fluoride labeled aptamer.
Kim HJ; Park JY; Lee TS; Song IH; Cho YL; Chae JR; Kang H; Lim JH; Lee JH; Kang WJ
PLoS One; 2019; 14(1):e0211047. PubMed ID: 30682091
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of modified PEG-anilinoquinazoline derivatives as potential agents for EGFR imaging in cancer by small animal PET.
Pantaleo MA; Mishani E; Nanni C; Landuzzi L; Boschi S; Nicoletti G; Dissoki S; Paterini P; Piccaluga PP; Lodi F; Lollini PL; Fanti S; Biasco G
Mol Imaging Biol; 2010 Dec; 12(6):616-25. PubMed ID: 20379787
[TBL] [Abstract][Full Text] [Related]
11. Extracellular domain shedding influences specific tumor uptake and organ distribution of the EGFR PET tracer 89Zr-imgatuzumab.
Pool M; Kol A; Lub-de Hooge MN; Gerdes CA; de Jong S; de Vries EG; Terwisscha van Scheltinga AG
Oncotarget; 2016 Oct; 7(42):68111-68121. PubMed ID: 27602494
[TBL] [Abstract][Full Text] [Related]
12. In Vitro and In Vivo Characterization of an
Lütje S; Franssen GM; Herrmann K; Boerman OC; Rijpkema M; Gotthardt M; Heskamp S
J Nucl Med; 2019 Jul; 60(7):1017-1022. PubMed ID: 30655329
[TBL] [Abstract][Full Text] [Related]
13. Targeting Fibroblast Activation Protein: Radiosynthesis and Preclinical Evaluation of an
Toms J; Kogler J; Maschauer S; Daniel C; Schmidkonz C; Kuwert T; Prante O
J Nucl Med; 2020 Dec; 61(12):1806-1813. PubMed ID: 32332144
[TBL] [Abstract][Full Text] [Related]
14.
Pyo A; Yun M; Kim HS; Kim TY; Lee JJ; Kim JY; Lee S; Kwon SY; Bom HS; Kim HS; Kim DY; Min JJ
J Nucl Med; 2018 Feb; 59(2):340-346. PubMed ID: 28916621
[TBL] [Abstract][Full Text] [Related]
15. Small-animal PET of melanocortin 1 receptor expression using a 18F-labeled alpha-melanocyte-stimulating hormone analog.
Cheng Z; Zhang L; Graves E; Xiong Z; Dandekar M; Chen X; Gambhir SS
J Nucl Med; 2007 Jun; 48(6):987-94. PubMed ID: 17504880
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of 4-[18F]fluorobenzoyl-FALGEA-NH2 as a positron emission tomography tracer for epidermal growth factor receptor mutation variant III imaging in cancer.
Denholt CL; Binderup T; Stockhausen MT; Poulsen HS; Spang-Thomsen M; Hansen PR; Gillings N; Kjær A
Nucl Med Biol; 2011 May; 38(4):509-15. PubMed ID: 21531288
[TBL] [Abstract][Full Text] [Related]
17. A novel multivalent (99m)Tc-labeled EG2-C4bpα antibody for targeting the epidermal growth factor receptor in tumor xenografts.
Li C; Zhang Y; Wang L; Feng H; Xia X; Ma J; Yuan H; Gao B; Lan X
Nucl Med Biol; 2015 Jun; 42(6):547-54. PubMed ID: 25779037
[TBL] [Abstract][Full Text] [Related]
18. (18)F-nanobody for PET imaging of HER2 overexpressing tumors.
Xavier C; Blykers A; Vaneycken I; D'Huyvetter M; Heemskerk J; Lahoutte T; Devoogdt N; Caveliers V
Nucl Med Biol; 2016 Apr; 43(4):247-52. PubMed ID: 27067045
[TBL] [Abstract][Full Text] [Related]
19. PET Imaging of Macrophage Mannose Receptor-Expressing Macrophages in Tumor Stroma Using 18F-Radiolabeled Camelid Single-Domain Antibody Fragments.
Blykers A; Schoonooghe S; Xavier C; D'hoe K; Laoui D; D'Huyvetter M; Vaneycken I; Cleeren F; Bormans G; Heemskerk J; Raes G; De Baetselier P; Lahoutte T; Devoogdt N; Van Ginderachter JA; Caveliers V
J Nucl Med; 2015 Aug; 56(8):1265-71. PubMed ID: 26069306
[TBL] [Abstract][Full Text] [Related]
20. Small-animal PET imaging of human epidermal growth factor receptor type 2 expression with site-specific 18F-labeled protein scaffold molecules.
Cheng Z; De Jesus OP; Namavari M; De A; Levi J; Webster JM; Zhang R; Lee B; Syud FA; Gambhir SS
J Nucl Med; 2008 May; 49(5):804-13. PubMed ID: 18413392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
